Pcm. Van De Kerkhof et al., Patient compliance and disease management in the treatment of psoriasis inthe Netherlands, DERMATOLOGY, 200(4), 2000, pp. 292-298
Background: Compliance behaviour and disease management are important issue
s in chronic skin diseases. Psoriasis patients are 'experts by experience'
because of ma ny yea rs of treatment. Therefore, it is re I eva nt to gathe
r data from patients on the actual use of antipsoriatic treatments. Objecti
ve: The following questions are addressed: (1) What is the present mode of
prescription and actual use of antipsoriatic treatments, including topical
treatments, photo(chemo)therapy and systemic treatments? (2) What informati
on do patients expect from their doctor, and do they actually receive this
information. Methods: To answer these questions, a questionnaire survey was
mailed to the subscribers of Psoriasis, the journal of the Dutch Psoriasis
Patients' Organisation. Results: (1) Major issues in the treatment of psor
iasis are (a) long-term management, (b) control of mild, moderate but also
extensive psoriasis and (c) control of psoriasis on difficult localisations
. Patients perceive itch, scaliness and visibility as major criteria for ef
ficacy. (2) Topical treatment is the mainstay in the management of psoriasi
s. Calcipotriol is the most prescribed drug. Photo(chemo)therapy has an int
ermediate position between topical and systemic treatments. UVB is prescrib
ed more th an twice as frequently as PUVA a nd 10% of the patients on photo
(chemo)therapy proved to be treated with UVB at home. Only 16% of the patie
nts were on a systemic treatment; methotrexate and acitretin were the most
frequently used systemic treatments. (3) More than 70% of the patients indi
cated that they had taken part in the selection of a treatment. In general,
the patients were satisfied about the contact with their dermatologist and
general practitioner. Compliance with the duration of treatment is limited
, especially with regard to topical treatment. Patient compliance with the
dose of the treatment is better. Again compliance is the worst in topical t
reatments. (4) Patients have a strong preference for an effective treatment
which is safe for long-term use. Only a minority of patients wants a fast
clearing treatment. Conclusion: Itch, scaliness and visibility provide the
most relevant information on the severity of psoriasis, as the patients per
ceive themselves. Treatment duration is often unrestricted, especially with
regard to topical treatments, which implies that the cumulative toxicity p
otential of these treatments may have a serious impact on their safety prof
ile. Patients regard it of importance to have a vote in the selection of th
e treatment and regard safety as more important than fast clearing. Copyrig
ht (C) 2000 S. Karger AG, Basel.